These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12520742)

  • 21. [Detection of glutathione S-transferase and lung resistance-related proteins in acute leukemia and its clinical significance].
    Zhang ZM; Xie ZX; Tan DR; Huang CH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):292-4. PubMed ID: 16045016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lung resistance protein analysis in testicular cancer].
    Mándoky L; Géczi L; Doleschall Z; Csuka O; Bodrogi I; Bak M
    Magy Onkol; 2002; 46(4):339-45. PubMed ID: 12563357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer.
    Aggarwal S; He T; Fitzhugh W; Rosenthal K; Feild B; Heidbrink J; Mesmer D; Ruben SM; Moore PA
    Gynecol Oncol; 2009 Dec; 115(3):430-7. PubMed ID: 19800108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the lung resistance protein in primary colorectal carcinomas.
    Pohl G; Suchomel RW; Stranzl T; Depisch D; Stiglbauer W; Filipits M; Pirker R
    Anticancer Res; 2001; 21(1A):201-4. PubMed ID: 11299735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
    Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of chemoresistance markers in women with epithelial ovarian carcinoma.
    Goff BA; Paley PJ; Greer BE; Gown AM
    Gynecol Oncol; 2001 Apr; 81(1):18-24. PubMed ID: 11277644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Establishment of cisplatin-induced multidrug resistant human epithelial ovarian cancer cell line 3AO/cDDP and its expressions of multidrug resistance proteins].
    Chen J; Yang R; Liu F
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):617-20. PubMed ID: 11372415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias--correlation to the expression of multidrug resistance proteins.
    Fichtner I; Paal K; Borgmann A; Badiali L; Wurm R; Henze G
    Anticancer Res; 2003; 23(3B):2657-64. PubMed ID: 12894554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].
    Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M
    Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Establishment of 5 resistant ovarian cancer cell strains and expression of resistance-related genes].
    Luan YZ; Li L; Li DR; Zhang W; Tang BJ
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):403-7. PubMed ID: 15312326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The clinical significance of lung resistance protein (LRP) gene expression in patients with acute leukemia].
    Ren J; Dong Z; Guo X; Wang F; Du X; Zhang X; Lin F; Yao E
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jan; 21(1):10-3. PubMed ID: 11876952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlations of EGFR and LRP to chemotherapy resistance and prognosis of ovarian cancer].
    Zhang J; Chen AP; Wang B; Zhao SP; Liu LZ; Dai SZ
    Ai Zheng; 2008 Dec; 27(12):1331-6. PubMed ID: 19080004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of reproducible low mass SELDI protein profiles specific to cisplatin resistance in human ovarian cancer cells.
    Britten RA; Hardy C; Vlahou A; Gregory B; Giri PS; Drake R
    Oncol Rep; 2005 Nov; 14(5):1323-30. PubMed ID: 16211304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.
    Cree IA; Kurbacher CM; Lamont A; Hindley AC; Love S;
    Anticancer Drugs; 2007 Oct; 18(9):1093-101. PubMed ID: 17704660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.
    Yang X; Xing H; Gao Q; Chen G; Lu Y; Wang S; Ma D
    Gynecol Oncol; 2005 May; 97(2):413-21. PubMed ID: 15863139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
    Shi W; Gu M; Liang L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting resistance to platinum-containing chemotherapy with the ATP tumor chemosensitivity assay in primary ovarian cancer.
    Neubauer H; Stefanova M; Solomayer E; Meisner C; Zwirner M; Wallwiener D; Fehm T
    Anticancer Res; 2008; 28(2A):949-55. PubMed ID: 18507041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
    Okamoto A; Nikaido T; Ochiai K; Takakura S; Saito M; Aoki Y; Ishii N; Yanaihara N; Yamada K; Takikawa O; Kawaguchi R; Isonishi S; Tanaka T; Urashima M
    Clin Cancer Res; 2005 Aug; 11(16):6030-9. PubMed ID: 16115948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythropoietin receptor function and expression in epithelial ovarian carcinoma.
    McBroom JW; Acs G; Rose GS; Krivak TC; Mohyeldin A; Verma A
    Gynecol Oncol; 2005 Dec; 99(3):571-7. PubMed ID: 16051335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.